Skip to content

3T Biosciences vs Revitope

3T Biosciences logo

3T Biosciences

3T is an immunotherapy company developing next-generation, transformative therapies for broad patient populations

26 employees · est. 2017 · South San Francisco, United...

VS
Revitope logo

Revitope

Powered for Precision: Revolutionizing immunotherapy to safely and effectively treat more cancers

6 employees · est. 2016 · Cambridge, United States

Revitope is the older company (2017 vs 2016); 3T Biosciences is the larger of the two.

Side-by-Side Comparison

3T Biosciences Revitope
Founded
2017 2016 older
Headquarters
South San Francisco, United States Cambridge, United States
Employees
26 larger 6
Industry
Biopharma, Biotechnology, Health Care Biotechnology, Health Care, Health and Wellness
Funding Stage
Series A Venture round
Total Funding
$52.00M $8.50M
Funding Rounds
3 1
Services
Development of transformative therapies, Treatment for solid tumors, Innovative immunotherapy solutions Not tracked yet
Target Customers
Patients with solid tumors, Broad patient populations, Healthcare providers Not tracked yet
Taxonomy
ImmunotherapyNext-generation TherapiesTransformative TherapiesSolid TumorsImmune-mediated DiseasesBroad Patient Populations +8 ImmunotherapyCancer TreatmentT Cell Redirecting BiologicsPrecision MedicineImmune-based TherapiesProgrammable Antibody Circuits +8
Website
3tbiosciences.com revitope.com
3T Biosciences logo

About 3T Biosciences

3T Biosciences, founded in 2017 and headquartered in the United States, is an emerging player in the Biopharma and Biotechnology sectors. The company is dedicated to revolutionizing immunotherapy by developing next-generation therapies aimed at treating solid tumors and other immune-mediated disease...

Revitope logo

About Revitope

Revitope, an early stage biotechnology company, is focused on revolutionizing immunotherapy to effectively treat a wide range of cancers. The company's Programmable Antibody Circuits (PACs) aim to redirect T cells to the surface of cancer cells, activating a potent immune response while expanding an...

Also comparing in this category

Comparing more than these two?

Get 3T Biosciences, Revitope and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does 3T Biosciences compare?

A PDF of 3T Biosciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

3T Biosciences was founded in 2017, based in South San Francisco, United States, with 26 employees. 3T Biosciences, founded in 2017 and headquartered in the United States, is an emerging player in the Biopharma and Biotechnology sectors. The company is dedicated to revolutionizing immunotherapy by d. Revitope was founded in 2016, based in Cambridge, United States, with 6 employees. Revitope, an early stage biotechnology company, is focused on revolutionizing immunotherapy to effectively treat a wide range of cancers. The company's Programmable Antibody Circuits (PACs) aim to red.
3T Biosciences has raised $52.00M and Revitope $8.50M. Latest stage: 3T Biosciences Series A, Revitope Venture round.
Both work in Biotechnology and Health Care and list immunotherapy, cancer treatment and oncology among their focus areas.

Compare 3T Biosciences with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at 3T Biosciences on 4 Jun 2026, and Revitope on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout